Erratum: Proliferative verrucous vs conventional leukoplakia: No significantly increased risk of HPV infection (Oral Oncology (2004) 40 (835-840) DOI: 10.1016/j.oraloncology.2004.02.007);Proliferative verrucous vs conventional leukoplakia: No significantly increased risk of HPV infection

Oral Oncology

Volumn 40, Issue 8, 2004, Pages 835-840

  Campisi, G ^a   Giovannelli, L ^a   Ammatuna, P ^a   Capra, G ^a   Colella, G ^b   Di Liberto, C ^a   Gandolfo, S ^c   Pentenero, M ^c   Carrozzo, M ^c   Serpico, R ^d   D'Angelo, M ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

^d UNIVERSITY OF BARI   (Italy)

Author keywords

HPV; Leukoplakia; PVL

Indexed keywords

VIRUS DNA;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DNA SEQUENCE; DRINKING BEHAVIOR; FEMALE; GENOTYPE; HUMAN; HUMAN TISSUE; INFECTION RISK; LEUKOPLAKIA; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; MOUTH MUCOSA; MUCOSA CELL; MULTICENTER STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROLIFERATIVE VERRUCOUS LEUKOPLAKIA; SMOKING HABIT; SQUAMOUS CELL CARCINOMA; VERRUCOUS CARCINOMA; VIRUS GENE; VIRUS INFECTION; WART VIRUS;

EID: 4043102633     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2004.08.006     Document Type: Erratum

References (32)

1. Hansen L.S., Olson J.A., Silverman S. Jr. Proliferative verrucous leukoplakia. A long-term study of thirty patients. Oral Surg. Oral Med. Oral Pathol. 60(3):1985;285-298
2. Silverman S., Gorsky M. Jr. Proliferative verrucous leukoplakia: a follow-up study of 54 cases. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 84(2):1997;154-157
3. Batsakis J.G., Suarez P., el-Naggar A.K. Proliferative verrucous leukoplakia and its related lesions. Oral Oncol. 35(4):1999;354-359
4. Napier S.S., Cowan C.G., Gregg T.A., Stevenson M., Lamey P.J., Toner P.G. Potentially malignant oral lesions in Northern Ireland: size (extent) matters. Oral Dis. 9(3):2003;129-137
5. Scheifele C., Reichart P.A. Is there a natural limit of the transformation rate of oral leukoplakia? Oral Oncol. 39(5):2003;470-475
6. Lodi G, Sardella A, Bez C, Demarosi F, Carrassi A. Interventions for treating oral leukoplakia (Cochrane Review). The Cochrane Library, Oxford, Update Software (1), 2002
7. Bouda M., Gorgoulis V.G., et al. Higt risk HPV types are frequently detected in potentially malignant and malignant oral lesions, but not in normal oral mucosa. Mod. Pathol. 13(6):2000;644-653
8. Gillison L., Koch W.M., et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J. Natl. Cancer Inst. 92:2000;721-728
9. Ringstrom E., Peters E., Hasegawa M., Posner M., Liu M., Kelsey K.T. Human papillomavirus type 16 and squamous cell carcinoma of the head and neck. Clin. Cancer Res. 8(10):2002;3187-3192
10. Scully C. Oral squamous cell carcinoma; from an hypothesis about a virus, to concern about possible sexual transmission. Oral Oncol. 38(3):2002;227-234
11. Palefsky J.M., Silverman S. Jr., Abdel-Salaam M., Daniels T.E., Greenspan J.S. Association between proliferative verrucous leukoplakia and infection with human papillomavirus type 16. J. Oral Pathol. Med. 24(5):1995;193-197
12. Praetorius F. HPV associated diseases of oral mucosa. Clin. Dermatol. 15:1997;399-413
13. Fettig A., Pogrel M.A., Silverman S. Jr., Bramanti T.E., Da Costa M., Regezi J.A. Proliferative verrucous leukoplakia of the gingiva. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 90(6):2000;723-730
14. Gopalakrishnan R., Weghorst C.M., et al. Mutated and wild-type p53 expression and HPV integration in proliferative verrucous leukoplakia and oral squamous cell carcinoma. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 83(4):1997;471-477
15. Miller C.S., Johnstone B.M. Human papillomavirus as a risk factor for oral squamous cell carcinoma: a meta-analysis, 1982-1997. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 91(6):2001;622-635
16. Reibel J. Prognosis of oral pre-malignant lesions: significance of clinical, histopathological, and molecular biological characteristics. Crit. Rev. Oral Biol. Med. 14(1):2003;47-62
17. Axèll T, Pindborg JJ, Smith CJ, van der Waal I. An International Collaborative Group on Oral White Lesions. Oral white lesions with special reference to precancerous and tobacco-related lesions: conclusions of an international symposium held in Uppsala Sweden, May 18-21 1994. J Oral Pathol Med 1996;25:49-54
18. Ammatuna P., Campisi G., et al. Presence of Epstein-Barr virus, cytomegalovirus and human papillomavirus in normal oral mucosa of HIV-infected and renal transplant patients. Oral Dis. 7(1):2001;34-40
19. Giovannelli L., Campisi G., et al. Human papillomavirus DNA in oral mucosal lesions. J. Infect. Dis. 185(6):2002;833-836
20. Kwok S., Higuchi R. Avoiding false positives with PCR. Nature. 339(6221):1989;237-238
21. Ammatuna P., Giovannelli L., et al. Presence of human papillomavirus and Epstein-Barr virus in the cervix of women infected with the human immunodeficiency virus. J. Med. Virol. 62(4):2000;410-415
22. Vernon S.D., Unger E.R., Williams D. Comparison of human papillomavirus detection and typing by cycle sequencing, line blotting, and hybrid capture. J. Clin. Microbiol. 38(2):2000;651-655
23. Dahlstrom K.R., Adler-Storthz K., et al. Human papillomavirus type 16 infection and squamous cell carcinoma of the head and neck in never-smokers: a matched pair analysis. Clin. Cancer Res. 9(7):2003;2620-2626
24. Ritchie J.M., Smith E.M., et al. Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx. Int. J. Cancer. 104(3):2003;336-344
25. Sugiyama M., Bhawal U.K., Dohmen T., Ono S., Miyauchi M., Ishikawa T. Detection of human papillomavirus-16 and HPV-18 DNA in normal, dysplastic, and malignant oral epithelium. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 95:2003;594-600
26. Murrah V.A., Batsakis J.G. Proliferative verrucous leukoplakia and verrucous hyperplasia. Ann. Otol. Rhinol. Laryngol. 103(8 Pt 1):1994;660-663
27. Krul E.J., Van De Vijver M.J., Schuuring E., Van Kanten R.W., Peters A.A., Fleuren G.J. Human papillomavirus in malignant cervical lesions in Surinam, a high-risk country, compared to the Netherlands, a low-risk country. Int. J. Gynecol. Cancer. 9(3):1999;206-211
28. Sebbelov A.M., Davidson M., et al. Comparison of human papillomavirus genotypes in archival cervical cancer specimens from Alaska natives, Greenland natives and Danish Caucasians. Microbes Infect. 2(2):2000;121-126
29. Zhang Z.Y., Sdek P., Cao J., Chen W.T. Human papillomavirus type 16 and 18 DNA in oral squamous cell carcinoma and normal mucosa. Int. J. Oral Maxillofac. Surg. 33(1):2004;71-74
30. Bouquot J.E. Oral verrucous carcinoma. Incidence in two US populations. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 86(3):1998;318-324
31. Murrah V.A., Gilchrist E.P., Arbeit J.M. Oral epithelial dysplasias in K14-HPV 16 transgenic mice esposed to estrogen. Development of a potential animal model of proliferative verrucous leucoplakia. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 90(4):2000;495
32. Ghazali N., Bakri M.M., Zain R.B. Aggressive, multifocal oral verrucous leukoplakia: proliferative verrucous leukoplakia or not. J. Oral Pathol. Med. 32(7):2003;383-392